Related Experiment Video
Updated: Dec 16, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Acute Myopericarditis with Pericardial Effusion and Cardiac Tamponade in a Patient with COVID-19
Richa Purohit1, Arjun Kanwal1, Anil Pandit2
1Internal Medicine Residency Program, MedStar Health, Baltimore, MD, USA.
Insights
Coronavirus disease 2019 (COVID-19) can cause rare heart complications like myopericarditis and cardiac tamponade. Early diagnosis and management are crucial for patients with these cardiovascular manifestations.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is a respiratory illness with emerging cardiovascular complications.
- Reports indicate a rise in cardiac manifestations alongside increasing COVID-19 cases.
Observation:
- An 82-year-old female with comorbidities presented with COVID-19 symptoms.
- She developed myopericarditis, pericardial effusion, and cardiac tamponade.
- An echocardiogram revealed an enlarging pericardial effusion and right ventricular collapse.
Findings:
- Electrocardiogram (EKG) showed diffuse T-wave inversions and prolonged QT interval.
- Troponin levels were mildly elevated.
- Pericardiocentesis successfully drained 400 cc of exudate, relieving tamponade.
Implications:
- COVID-19 can lead to acute myopericarditis and pericardial effusion, even without severe respiratory disease.
- This case underscores the importance of recognizing rare cardiac manifestations of COVID-19.
- Prompt diagnosis and management of cardiac tamponade in COVID-19 patients are essential.
Abstract:
BACKGROUND Coronavirus disease 2019 (COVID-19) is primarily a respiratory illness. However, with rising numbers of cases, multiple reports of cardiovascular manifestations have emerged. We present a case of COVID-19 infection complicated by myopericarditis and tamponade requiring drainage. CASE REPORT An 82-year-old woman with multiple comorbidities presented with five days of productive cough, fever with chills, and intermittent diarrhea. She tested positive for COVID-19. Index EKG revealed new diffuse T-wave inversions and a prolonged QT interval (>500 ms). Troponin was mildly elevated without any anginal symptoms. Hydroxychloroquine and azithromycin were not initiated due to concerns about QT prolongation. The echocardiogram revealed preserved left ventricular (LV) function, a small global pericardial effusion, and apical hypokinesis. Serial echocardiograms revealed an enlarging circumferential pericardial effusion with pacemaker wire reported as 'piercing' the right ventricular (RV) apex alongside early diastolic collapse of the right ventricle, suggesting echocardiographic tamponade. Chest CT revealed extension of the RV pacemaker lead into the pericardial fat. Interestingly, on comparison with a previous chest CT from 2019, similar lead positions were confirmed. Pericardiocentesis was performed with removal of 400 cc exudate. CONCLUSIONS Acute myopericarditis and pericardial effusion can occur in COVID-19 infection, even in the absence of severe pulmonary disease. This case highlights the importance of awareness of rare cardiac manifestations of COVID-19 in the form of acute myopericarditis and cardiac tamponade and their early diagnosis and management.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests

